Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-10-25 | Future report Set alerts | |
Q2 2022 | 2022-07-27 | 0.76 | 0.76 |
Q1 2022 | 2022-05-04 | 0.70 | 0.70 |
Q4 2021 | 2022-01-26 | 1.07 | 1.07 |
Q3 2021 | 2021-10-27 | 0.80 | 0.80 |
Q2 2021 | 2021-07-28 | 0.71 | 0.71 |
Q1 2021 | 2021-04-28 | 0.63 | 0.63 |
Q4 2020 | 2021-01-27 | 0.84 | 0.84 |
Q2 2020 | 2020-07-29 | -0.07 | -0.96 |
Q1 2020 | 2020-04-29 | 0.51 | 0.20 |
2016-04-28 | Boost Price Target | Needham & Company LLC | Buy | $48.00 to $49.00 |
2016-04-28 | Reiterated Rating | Leerink Swann | Buy | |
2016-03-07 | Reiterated Rating | Needham & Company LLC | Buy | |
2016-01-28 | Reiterated Rating | Leerink Swann | Buy | $51.00 to $50.00 |
2016-01-28 | Reiterated Rating | Needham & Company LLC | Buy | $48.00 |
2016-01-07 | Reiterated Rating | Needham & Company LLC | Buy | $51.00 |
2015-11-17 | Reiterated Rating | Deutsche Bank | Buy | |
2015-11-17 | Reiterated Rating | Deutsche Bank AG | Buy | |
2015-11-16 | Reiterated Rating | Needham & Company LLC | Buy | |
2015-11-16 | Reiterated Rating | Leerink Swann | Buy | |
2015-11-13 | Lower Price Target | Leerink Swann | Outperform | $53.00 to $51.00 |
2015-10-22 | Reiterated Rating | Leerink Swann | Buy | $60.00 to $53.00 |
2015-10-22 | Reiterated Rating | Needham & Company LLC | Buy | $51.00 |
2015-10-22 | Lower Price Target | Northland Securities | Market Perform | $58.00 to $44.00 |
2015-10-12 | Upgrade | Ladenburg Thalmann | Neutral to Buy | $55.00 |
2015-10-05 | Lower Price Target | Leerink Swann | Outperform | $66.00 to $60.00 |
2015-10-05 | Reiterated Rating | Needham & Company LLC | Buy | $60.00 |
2015-08-27 | Reiterated Rating | Piper Jaffray | Neutral | $51.00 |
2015-08-27 | Reiterated Rating | Piper Jaffray Cos. | Neutral | $51.00 |
2015-07-23 | Reiterated Rating | Deutsche Bank | Buy | $71.00 |
2015-07-22 | Reiterated Rating | Needham & Company LLC | Buy | $56.00 to $60.00 |
2015-07-22 | Downgrade | Northland Securities | Outperform to Market Perform | $65.00 to $58.00 |
2015-05-19 | Boost Price Target | Leerink Swann | Outperform | $60.00 to $64.00 |
2015-05-15 | Initiated Coverage | Northland Capital Partners | Outperform | $65.00 |
2015-05-14 | Initiated Coverage | Northland Securities | Outperform | $65.00 |
2015-05-04 | Initiated Coverage | Deutsche Bank | Buy to Buy | $63.00 to $63.00 |
2015-04-24 | Downgrade | Ladenburg Thalmann | Buy to Neutral | $55.00 |
2015-04-23 | Reiterated Rating | Piper Jaffray | Neutral | $47.00 to $51.00 |
2015-04-23 | Boost Price Target | Needham & Company LLC | Buy | $54.00 to $56.00 |
2015-03-16 | Initiated Coverage | KeyBanc | Sector Weight | |
2015-03-16 | Initiated Coverage | KeyCorp | Sector Weight | |
2015-02-13 | Initiated Coverage | Leerink Swann | Outperform | $60.00 |
2015-01-28 | Boost Price Target | Summer Street | Buy | $46.00 to $56.00 |
2015-01-16 | Boost Price Target | Needham & Company LLC | Buy | $49.00 to $52.00 |
2014-12-03 | Boost Price Target | Needham & Company LLC | Buy | $45.00 to $49.00 |
2014-03-13 | Upgrade | Ladenburg Thalmann | Neutral to Buy | |
2014-02-14 | Downgrade | Ladenburg Thalmann | Buy to Neutral | $42.00 to $51.75 |
2014-02-14 | Boost Price Target | Summer Street | $53.00 | |
2014-02-13 | Reiterated | Needham | Buy | $48 to $54 |
2014-02-11 | Reiterated | Needham | Buy | $45 to $48 |
2014-02-11 | Boost Price Target | Needham & Company LLC | Buy | $45.00 to $48.00 |
2013-12-16 | Boost Price Target | Needham & Company LLC | $40.00 to $45.00 | |
2013-10-25 | Reiterated | Needham | Buy | $37 to $40 |
2013-10-25 | Boost Price Target | Needham & Company LLC | Buy | $37.00 to $40.00 |
2013-07-25 | Reiterated | Ladenburg Thalmann | Buy | $36.25 to $42 |
2012-07-25 | Initiated | Ladenburg Thalmann | Buy | $38.70 |
2010-05-07 | Upgrade | CL King | Underperform to Neutral | |
2009-01-06 | Reiterated | Needham | Buy | $25 to $36 |
2016-04-28 | Boost Price Target | Needham & Company LLC | Buy | $48.00 to $49.00 |
2016-04-28 | Reiterated Rating | Leerink Swann | Buy | |
2016-03-07 | Reiterated Rating | Needham & Company LLC | Buy | |
2016-01-28 | Reiterated Rating | Leerink Swann | Buy | $51.00 to $50.00 |
2016-01-28 | Reiterated Rating | Needham & Company LLC | Buy | $48.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CNMD 201 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 4.81M |
Vanguard Group, Inc | 3.34M |
BlackRock Fund Advisors | 2.10M |
EARNEST PARTNERS LLC | 2.07M |
Capital Research Global Investors | 1.74M |
AMERIPRISE FINANCIAL INC | 1.37M |
Champlain Investment Partners, LLC | 1.32M |
STATE STREET CORP | 1.08M |
BANK OF AMERICA CORP /DE/ | 0.93M |
JPMORGAN CHASE & CO | 0.88M |
Invesco Ltd. | 0.81M |
LOOMIS SAYLES & CO L P | 0.77M |
MACQUARIE GROUP LTD | 0.73M |
PRINCIPAL FINANCIAL GROUP INC | 0.72M |
BlackRock Institutional Trust Company, N.A. | 0.68M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
CORASANTI JOSEPH J President & CEO | 0.57% (156356) | CNMD / IIVI / |
CORASANTI EUGENE R | 0.31% (84558) | CNMD / |
SHALLISH ROBERT D JR Vice President/Finance/CFO | 0.24% (64966) | CNMD / |
Hartman Curt R | 0.16% (42504) | CNMD / |
TRYNISKI MARK E | 0.12% (31678) | CBU / CNMD / |
Snyder Mark D EVP Mfg. Operations & Supply | 0.07% (20130) | CNMD / |
Berge Terence M VP Corp. Treasurer | 0.07% (19908) | CNMD / |
Darling Joseph G President ConMed Linvatec | 0.06% (16837) | ANIK / CNMD / |
Jones Gregory Renard Vice President-Corporate QA/RA | 0.06% (15465) | CNMD / |
Cohen Heather L VP CORP HR&DEPUTY GEN COUNSEL | 0.05% (14538) | CNMD / |
GOLDEN JO ANN | 0.05% (13782) | CNMD / |
CONCANNON BRIAN | 0.04% (11739) | CNMD / HAE / |
Farkas Charles | 0.04% (11707) | CNMD / |
Kuyper Dirk | 0.04% (10739) | ATEC / CNMD / |
SCHWARTZ STUART J | 0.04% (10600) | CNMD / |
Workman John L | 0.04% (10239) | CCP / CNMD / FSS / OCR / |
BRONSON DAVID M | 0.03% (7239) | CNMD / |
Lande Jerome J. | 0.03% (7000) | CNMD / ITRI / |
Beyer Pat President-Conmed International | 0.02% (6682) | CNMD / |
DANIELS BRUCE | 0.02% (5000) | CNMD / |
ABRAHAM WILLIAM Senior Vice President | 0.02% (4872) | CNMD / |
Aronson Martha Goldberg | 0.01% (3739) | CNMD / CSII / ECL / HTCH / MEI / |
KENNEDY JOHN JED VP GM GI | 0.01% (3178) | CNMD / |
Peters Stanley W III VP GM General Surgery | 0.01% (2983) | CNMD / |